A long-ago ancestor of the modern domestic dog is alive today in the form of the canine transmissible venereal tumor (CTVT). This tumor was fi rst identifi ed in the late 1800s when it was found to be transferred to new hosts through tumor cells ( 1) . We now know that the tumor is naturally transmitted between dogs by direct contact, primarily through coitus or activities that permit sloughing of cells ( 2) . The tumors are rarely metastatic and most tumors regress within a few months, leaving previously infected dogs with immunity. DNA analysis provides strong evidence that all CTVTs studied thus far are from a single source, one that existed before the dispersal of dog breeds around the world ( 3, 4) . On page 437 of this issue, Murchison et al. ( 5) describe the first whole-genome sequence of CTVT, sampled from two tumors: one from a random-bred Australian Aboriginal camp dog and the other from a purebred American cocker spaniel from Brazil.
Sequence analysis of the two tumors revealed ~1.7 million somatic variants shared between them. These variants are presumed to have arisen during the initial malignant transformation or in the years of tumor passage before separation of the tumors by geographic boundaries. The number of somatic mutations is >100 times as large as the average mutation load of a human tumor, highlighting the long period over which mutations have accumulated and the number of alterations required to develop a stable colony of tumor cells. Mutations were scattered throughout the genome with more than 10,000 genes carrying at least one predicted protein-modifying genetic change. This list encompasses nearly half of the annotated genes from the dog reference sequence ( 6) and illuminates a cadre of genes and proteins necessary for cellular replication, maintenance of the tumor phenotype, and pathogenicity.
An examination of 23,782 single-nucleotide polymorphisms in both CTVTs and 1106 modern dogs and other canids places the origin of the tumor at ~11,000 years before present, with a second divergence of geographical tumor strains occurring <500 years ago. Principal component analysis suggests that the fi rst dog with CTVT was a member of the ancient dog group, the dog breeds closest to the wolf ( 7) . Pairwise distance calculations place the Alaskan Malamute, a 4000-year-old breed that originally came to America from Eastern Asia, as the closest living relative of CTVT. In addition, the founder animal carried a mixture of "wolfl ike and doglike" alleles and was likely medium to large in size with short, straight fur, a black or agouti coat, prick ears, and a meso-to dolicocephalic head shape (see the fi gure). Dog fanciers will note that this description fi ts the modern Alaskan Malamute, but could also match that of any number of large spitz-type dogs.
Naturally occurring transmissible tumors are extremely rare. The only other known example is the Tasmanian devil facial tumor disease (DFTD), which was fi rst identifi ed in 1996 and has spread rapidly throughout the devil population. Unlike the canine tumor, DFTD is highly virulent, metastasizes readily, and is ultimately fatal ( 8) . Sequencing of DFTD revealed a three-to eightfold increase in somatic mutations compared to human tumors as opposed to the >100-fold increase
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Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892-8000, USA. E-mail: eostrand@mail.nih.gov and ribosomal RNA (rRNA) before and after a chemical induction of neuron plasticity. The authors observed a transient increase in mRNA and rRNA in dendrites upon neuron activation. This increase was mimicked by treatment with a protease and was not prevented by a transcription blocker, which suggests that the increase resulted from unmasking of RNA from RNA binding proteins, or disassembly of granules upon neuron activation, not from mRNA that was newly transcribed in the soma and then transported to dendrites. The unmasking event correlated with an increase in local β-actin synthesis; this suggests that the mRNA is in a latent protected state in the granule, which becomes unmasked for translation when the neuron undergoes plasticity. Such a mechanism may localize the expression of β-actin in dendrites and axons to promote cytoskeletal remodeling during synaptic plasticity or axon navigation.
To what extent do the properties described by Park et 
The two studies suggest that there must be elements sensitive to signaling that allow the release of an mRNA from the granule. It was recently shown that mRNAs are repressed at the elongation step of translation in the granule, waiting to be reactivated for translation, contrary to the current assumption that they are repressed at the initiation step ( 13) . Future studies should elucidate the number of times a single mRNA molecule can be translated.
Labeling techniques may also exert an infl uence on the speed, dynamics, and packing in an RNA granule. Anticipated improvements in labeling techniques, with brighter and smaller dyes, may refi ne our views.
PERSPECTIVES
in the canine tumor ( 9) . This likely relates to the age of the tumor as DFTD has been acquiring mutations for ~20 years, whereas CTVT has been evolving for >10,000 years. In contrast to CTVT, DFTD is driving its population toward extinction, which will lead eventually to its own demise ( 8) . It is possible that the canine tumor also started as an aggressive cancer, but that it evolved into a colonizing pathogen. A close comparison of the mutations found in each tumor type might reveal variants important for understanding the unique behaviors of the two tumors.
One feature shared by both tumors is their appearance in populations of low diversity. The Tasmanian devil is a small island species with little genetic heterogeneity ( 10) . Analysis of the major histocompatibility loci in CTVTs reveals that the source individual was inbred and largely homozygous at the most variable dog leukocyte antigen haplotypes ( 3) . The restricted gene pools in both founding populations may have aided the initial establishment of a clonally transmissible tumor. In the case of the dog, however, the population did not stay isolated, and the introduction of new major histocompatibility complex alleles may have kept tumor growth at bay. By comparison, Tasmanian devils are a small, closed popu-A fg h a n H o u n d S ib e r ia n H u s k y A l a s k a n M a l a m u t e S h a r -p e i
Pom eran ian Chihuahua Pekin gese Sh ih-Tzu Br us se ls Gr iff on Pu g P a p il lo n M in ia tu re P in s c h e r A m e r ic a n C o c k e r S p a n ie l E n g li s h C o c k e r S p a n ie l E n g l i s h S p r i n g e r S p a n i e l C a v a l i e r K i n g C h a r l e s S p a n i e l I r i s h W a t e r S p a n i e l B r i t t a n y G e r m a n S h o r t -h a i r e d P o i n t e r PERSPECTIVES lation, and there is therefore little hope of acquiring new resistance alleles. For generations, the modern dog has served as little more than a culture medium for CTVT. The genome sequence of this living fossil will, together with the discovery of new mutations that control the phenotypes of modern dogs, provide deeper insight into the appearance and perhaps even the behavior of the ancient dog. In addition, the sequence analysis will reveal information about the evolutionary history of the tumor. For example, CTVT has evolved methods of fooling the host's immune system, allowing it to establish a colony long enough for transfer between individuals to occur. Elucidation of these mechanisms based on the accumulation and position of mutations may help us understand the means by which pathogens escape host surveillance. This domestic dog tumor provides us with a unique system for answering some intriguing questions, making one wonder what else is hiding in the doghouse.
